News | June 20, 2011

PET/CT System Designed to Boost Patient Comfort

June 8, 2011 — GE Healthcare announced the release of its Optima PET/CT 560, which offers efficiency and investment protection with the capability to grow with the future needs of a clinical practice.

From the uninterrupted full head-to-toe exam to the dose reduction features, the Optima PET/CT 560 was designed to help physicians put patients’ needs first. The Optima PET/CT 560 enables a full 2-meter scan range, which is especially important when imaging skin and bone.

Clinicians can complete a full head-to-toe scan in one pass for greater patient comfort and convenience, and position taller patients on the table with greater ease, thus saving up to 15 minutes per exam by eliminating patient repositioning and potentially boosting scanning efficiency and patient throughput.

Advanced GE Vue Point HD intelligent 3-D iterative reconstruction technique enhances resolution for image quality that helps enable clinicians to confidently detect small lesions and increase quantitative accuracy.

Based on the Broselow-Luten Pediatric system, GE Healthcare’s default PET/CT protocols are specifically designed to help reduce computed tomography (CT) radiation exposure in FDG pediatric exams to meet ALARA (as low as reasonably achievable) guidelines. With a GE-developed interface dedicated to pediatric examinations, physicians select from color-coded protocols set in advance to suit a child’s specific weight.

In addition, the Optima PET/CT 560 uses a 3-D modulation algorithm, which automatically adjusts the mA as clinicians scan along the X-Y-Z axes. The modulation maintains CT image quality, yet dose is reduced up to 40 percent.

The Optima PET/CT 560 is built for growth; the system is fully upgradeable to the GE Healthcare Discovery PET/CT 600 series as department needs grow and change. Available in 8-slice or 16-slice configurations, the Optima PET/CT 560 can be operated as a standalone CT scanner.

The user interface is simplified for fast exam setup, and the compact and ergonomic operator console is designed for flexibility and comfort. Starting with pre-scan and through to post-processing, the Optima PET/CT 560 can help make the entire scanning experience streamlined and efficient. Daily Quality Assurance at the start of the scanning day is quick and efficient with one-button push and less than 10 minutes a day, with no additional exposure to the staff with the GE automated source loader. Fast reconstruction times deliver images to clinicians sooner, allowing decision-making before a patient is even off the table.

For more information:

Related Content

Imaging agent helps predict success of lung cancer therapy
News | Oncology Diagnostics | March 08, 2018
March 8, 2018 – Doctors contemplating the best therapy for...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows).

In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.

News | Prostate Cancer | March 07, 2018
An Italian study featured in the March i
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Overlay Init